Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Head and Neck Cancer

Free Subscription Articles published in PLoS One Retrieve available abstracts of 175 articles: HTML format

Single Articles

January 2025
1. SHANKAR V, Seethapathy J, Srinivas S, Nandhan R, et al
   Oncologists' views on ototoxicity monitoring in head and neck cancer patients: A South Indian qualitative study.
   PLoS One. 2025;20:e0312847.
   PubMed     Abstract available
   
   
   
2. XIE H, Li M, Chen Z, Zheng Y, et al
   Association of metformin use with risk and survival outcome of esophageal cancer in patients with diabetes: A systematic review and meta-analysis.
   PLoS One. 2025;20:e0310687.
   PubMed     Abstract available
   
   
   
3. WAKISAKA N, Moriyama-Kita M, Kondo S, Kobayashi E, et al
   Distinct immunological features of oropharyngeal cancer peritumoral tonsillar tissues from inflammatory tonsils and regional lymph nodes: A pilot study.
   PLoS One. 2025;20:e0316102.
   PubMed     Abstract available
   
   
   
4. YANG L, Yu L, Du X, Cui Y, et al
   Study of PEG-rhG-CSF for the prevention of neutropenia in concurrent chemoradiotherapy for nasopharyngeal carcinoma.
   PLoS One. 2025;20:e0315001.
   PubMed     Abstract available
   
   
   
5. TAENGSAKUL N, Nivatpumin P, Chotchutipan T, Tungfung S, et al
   Carotid artery stenosis and ischemic cerebrovascular events after radiotherapy in patients with head and neck cancer.
   PLoS One. 2025;20:e0314861.
   PubMed     Abstract available
   
   
   
6. CHOI W, Kwak BK, Jung J, Park S, et al
   Feasibility of rabbit auricular VX2 tumor model as an experimental model for intra-arterial embolization.
   PLoS One. 2025;20:e0316282.
   PubMed     Abstract available
   
   
   
7. ZHOU L, Yang M, Luo J, Zang H, et al
   Deep learning based analysis of G3BP1 protein expression to predict the prognosis of nasopharyngeal carcinoma.
   PLoS One. 2025;20:e0315893.
   PubMed     Abstract available
   
   
   
8. QIU Z, Yu S, Zheng L, Lou Y, et al
   Global burden of thyroid cancer in adolescents and young adults (aged 15-39 years) from 1990 to 2021: A systematic analysis of the Global Burden of Disease Study 2021.
   PLoS One. 2025;20:e0318605.
   PubMed     Abstract available
   
   
   
9. ZHANG ZX, Huang CM, Suo YX, Xie L, et al
   Trends in incidence and mortality of laryngeal cancer in china from 2004 to 2018: Projections to 2033 and decomposition analysis.
   PLoS One. 2025;20:e0318423.
   PubMed     Abstract available
   
   
   
10. SATO S, Ohata E, Nakatani E, Hawke P, et al
    High mean corpuscular volume as a predictor of esophageal cancer: A cohort study based on the Japanese Shizuoka Kokuho Database.
    PLoS One. 2025;20:e0318791.
    PubMed     Abstract available
    
    
    
11. KONG F, Han B, Wu Z, Chen J, et al
    Explore the possible influence of Sjogren's syndrome on thyroid cancer: A literature data mining and meta-analysis.
    PLoS One. 2025;20:e0318747.
    PubMed     Abstract available
    
    
    
12. AMINU K, Aladelusi TO, Adisa AO, Ezeagu CN, et al
    Epidemiology, literacy, risk factors, and clinical status of oral cancer in East Africa: A scoping review.
    PLoS One. 2025;20:e0317217.
    PubMed     Abstract available
    
    
    
13. KIM J, Park KA, Han K, Jung JH, et al
    Ocular motor cranial neuropathy and risk of thyroid cancer: A Korean population-based study.
    PLoS One. 2025;20:e0319872.
    PubMed     Abstract available
    
    
    
14. NICHOLAS B, Bailey A, McCann KJ, Walker RC, et al
    Comparative analysis of protein expression between oesophageal adenocarcinoma and normal adjacent tissue.
    PLoS One. 2025;20:e0318572.
    PubMed     Abstract available
    
    
    
15. LUO T, Zhou R, Sun Y
    The impact of postoperative glucocorticoids on complications after head and neck cancer surgery with free flap reconstruction: A retrospective study.
    PLoS One. 2025;20:e0319655.
    PubMed     Abstract available
    
    
    
16. ZHAO M, Yao J, Wang J, Shen X, et al
    Effectiveness of rehabilitation training on radiotherapy-related abnormalities of voice function in head and neck cancer patients: A systematic review and meta-analysis.
    PLoS One. 2025;20:e0318577.
    PubMed     Abstract available
    
    
    
17. LIU Y, Kong X, Sun Q, Cui T, et al
    Identification and validation of the common pathogenesis and hub biomarkers in Papillary thyroid carcinoma complicated by rheumatoid arthritis.
    PLoS One. 2025;20:e0317369.
    PubMed     Abstract available
    
    
    
18. MUANGWONG P, Tungkasamit T, Samakgarn V, Chumachote A, et al
    Effect of immunonutrition during concurrent chemoradiotherapy on acute oral mucositis in head and neck cancer patients: A prospective randomized study.
    PLoS One. 2025;20:e0320145.
    PubMed     Abstract available
    
    
    
19. BAIK YS, Lee H, Kim YJ, Chung JW, et al
    Early detection of esophageal cancer: Evaluating AI algorithms with multi-institutional narrowband and white-light imaging data.
    PLoS One. 2025;20:e0321092.
    PubMed     Abstract available
    
    
    
20. TUOMI L, Parris TZ, Rawshani A, Andersson E, et al
    Genetic, clinical, lifestyle and sociodemographic risk factors for head and neck cancer: A UK Biobank study.
    PLoS One. 2025;20:e0318889.
    PubMed     Abstract available
    
    
    
21. XUE L, Gou S, Zhang Y, Yuan R, et al
    Comprehensive analysis of CMTM family and immune infiltration in esophageal carcinoma.
    PLoS One. 2025;20:e0321037.
    PubMed     Abstract available
    
    
    
22. MASTRONICOLA R, Kayser E, Le Roux P, Barrat A, et al
    Study of the survival of patients with head and neck cancer in relation to Circulating Tumor Cells (CTCs).
    PLoS One. 2025;20:e0320485.
    PubMed     Abstract available
    
    
    
23. HU Q, Lv S, Wang X, Pan P, et al
    Global burden and future trends of head and neck cancer: a deep learning-based analysis (1980-2030).
    PLoS One. 2025;20:e0320184.
    PubMed     Abstract available
    
    
    
24. LIU DS, Allan Z, Tie J, Hall K, et al
    Multi-omics evaluation of peritoneal fluid in gastroesophageal cancer (OMEGCA): protocol for a prospective multicentre cohort study to detect occult peritoneal metastases in patients undergoing curative-intent treatment.
    PLoS One. 2025;20:e0318615.
    PubMed     Abstract available
    
    
    
25. FREDERICK MJ, Perez-Bello D, Yadollahi P, Castro P, et al
    Reliable RNA-seq analysis from FFPE specimens as a means to accelerate cancer-related health disparities research.
    PLoS One. 2025;20:e0321631.
    PubMed     Abstract available
    
    
    
26. ZHENG Z, Wu J, Cao B, Bei Y, et al
    Comparative effectiveness of surgery versus radiotherapy for non-nasopharyngeal head and neck lymphoepithelial carcinoma: An IPTW propensity score analysis.
    PLoS One. 2025;20:e0321318.
    PubMed     Abstract available
    
    
    
27. COLLI SL, Boycho ME, Papendieck P, Mangone FM, et al
    Prevalent genetic alterations in pediatric thyroid carcinoma: Insights from an Argentinean study.
    PLoS One. 2025;20:e0323271.
    PubMed     Abstract available
    
    
    
28. LUO Y, Ye Y, Saibaidoula Y, Zhang Y, et al
    Multifaceted investigations of PSMB8 provides insights into prognostic prediction and immunological target in thyroid carcinoma.
    PLoS One. 2025;20:e0323013.
    PubMed     Abstract available
    
    
    
29. ZHANG M, Huang Y, Zhang S, Peng S, et al
    The epidemiology and risk factors of anal and oropharyngeal human papillomavirus (HPV) in males living with human immunodeficiency virus (HIV): A protocol for systematic review and meta-analysis.
    PLoS One. 2025;20:e0320899.
    PubMed     Abstract available
    
    
    
30. RAO S, Wu H, Zhang G, Dong W, et al
    A comparative analysis of the burden, trends and inequalities of tracheal, bronchus, and lung cancer in India from 2000 to 2021: A systematic analysis for the Global Burden of Disease study 2021.
    PLoS One. 2025;20:e0322646.
    PubMed     Abstract available
    
    
    
31. MAHMOUD AA, Raih MF, Sage EE, Ali QM, et al
    The impact of mutations on TP53 protein and MicroRNA expression in HNSCC: Novel insights for diagnostic and therapeutic strategies.
    PLoS One. 2025;20:e0307859.
    PubMed     Abstract available
    
    
    
32. YAO XR, Xiao FZ, Xiao WT, Huang CQ, et al
    C16orf74 is a novel prognostic biomarker and associates with immune infiltration in head and neck squamous cell carcinoma.
    PLoS One. 2025;20:e0322701.
    PubMed     Abstract available
    
    
    
33. TEKETELEW BB, Berta DM, Chane E, Mekuanint A, et al
    Diagnostic accuracy of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in differentiating thyroid tumors: A systematic review and meta-analysis.
    PLoS One. 2025;20:e0322382.
    PubMed     Abstract available
    
    
    
34. WU M, Chen H, Zhang W, Feng X, et al
    Trends, levels, and projections of Head and Neck Cancer in China between 2000 and 2021: Findings from the Global Burden of Disease 2021.
    PLoS One. 2025;20:e0322533.
    PubMed     Abstract available
    
    
    
35. NA Y, Park M, Jung YG
    Exploring postoperative nasal airflow dynamics and impact on crust formation and mucosal healing after endoscopic tumor resection using computational fluid dynamics analysis.
    PLoS One. 2025;20:e0323560.
    PubMed     Abstract available
    
    
    
36. LI H, Liang X, Qin S, Chen X, et al
    First-line durvalumab therapy alone or in combination with tremelimumab for metastatic head and neck squamous cell carcinoma: A cost-effectiveness analysis.
    PLoS One. 2025;20:e0324057.
    PubMed     Abstract available
    
    
    
37. TERAYAMA M, Imamura Y, Kitazawa T, Miyazaki N, et al
    Study protocol: The effect of a low-carbohydrate enteral nutrition formula on postoperative hyperglycemia in non-diabetic patients with esophageal cancer: A randomized exploratory phase II trial (ENLICHE study).
    PLoS One. 2025;20:e0325039.
    PubMed     Abstract available
    
    
    
38. LI R, Strilic B, Jin YJ, Shao J, et al
    The tumor suppressor FAT1 controls YAP/TAZ protein degradation and tumor cell proliferation through E3 ligase MIB2.
    PLoS One. 2025;20:e0325535.
    PubMed     Abstract available
    
    
    
39. XU C, Wang Z, Zhou J, Hu F, et al
    Application research of artificial intelligence software in the analysis of thyroid nodule ultrasound image characteristics.
    PLoS One. 2025;20:e0323343.
    PubMed     Abstract available
    
    
    
40. CZERWINSKI MD, Zwijnenburg EM, Arens AIJ, Van Engen ACH, et al
    Sentinel NOSE: Prospective feasibility study on sentinel lymph node biopsy in bulky nasal vestibule cancer.
    PLoS One. 2025;20:e0325764.
    PubMed     Abstract available
    
    
    
41. HUSTED C, Adrianowycz S, Peterson C, DeWitt SB, et al
    Characterization of the genomic landscape of canine oral osteosarcoma reveals similarities with appendicular osteosarcoma.
    PLoS One. 2025;20:e0325181.
    PubMed     Abstract available
    
    
    
42. HAN JW, Zhong Y, Zhong J, Zeng WJ, et al
    First-line toripalimab plus chemotherapy versus chemotherapy for advanced esophageal squamous cell carcinoma: A cost-effectiveness analysis.
    PLoS One. 2025;20:e0325808.
    PubMed     Abstract available
    
    
    
43. ZHANG J, Yue K, Wu Y, Jing C, et al
    Multi-omics analysis and single-cell sequencing revealed the lysosome associated molecular subtypes and prognostic model development of papillary thyroid carcinoma.
    PLoS One. 2025;20:e0325486.
    PubMed     Abstract available
    
    
    
44. MUNPOLSRI P, Su CW, Yang HF, Hsu TH, et al
    Changes in risk habits and influencing factors in the Taiwan oral cancer screening program.
    PLoS One. 2025;20:e0320461.
    PubMed     Abstract available
    
    
    
45. DING M, Yu S, Chen Y, Liu Y, et al
    Space-time analysis of head and neck cancer in Asia and its 34 countries and territories (1990-2021): Implications from the Global Burden of Disease Study 2021.
    PLoS One. 2025;20:e0326177.
    PubMed     Abstract available
    
    
    
46. YU SC, Tong SS, Chen YL, Cheng YF, et al
    Efficacy and safety of cisplatin + docetaxel + 5-FU + leucovorin + methotrexate and epirubicin combination chemotherapy for advanced esophageal cancer.
    PLoS One. 2025;20:e0326056.
    PubMed     Abstract available
    
    
    
47. LI M, Li L, Wang X, Zhao Y, et al
    Whole genome sequencing revealed esophageal squamous cell carcinoma related biomarkers.
    PLoS One. 2025;20:e0323915.
    PubMed     Abstract available
    
    
    
48. ZENG H, Li Z, Chen Z, Tang S, et al
    Impact of monitor unit optimization in volumetric modulated arc therapy planning for nasopharyngeal carcinoma.
    PLoS One. 2025;20:e0327153.
    PubMed     Abstract available
    
    
    
49. GUO Q, Dong D, Dang Z, Huang S, et al
    The adverse events of toripalimab in nasopharyngeal carcinoma based on FAERS database and bibliometric analysis.
    PLoS One. 2025;20:e0326216.
    PubMed     Abstract available
    
    
    
50. GHANEM AS, Trefan L, Marton I, Fadgyas-Freyler P, et al
    Oral cancer in Hungary: An epidemiological profile (2015-2019).
    PLoS One. 2025;20:e0327566.
    PubMed     Abstract available
    
    
    
51. YUWANATI M, Thiyagarajan S, Ealla KKR, Jain Y, et al
    Graph attention networks for predicting drug-gene association of glucocorticoid in oral squamous cell carcinoma: A comparison with GraphSAGE.
    PLoS One. 2025;20:e0327619.
    PubMed     Abstract available
    
    
    
52. TELLMAN RS, Donders DNV, Arens AIJ, Boeve K, et al
    [18F]FDG PET/CT to reduce the need for sentinel lymph node biopsy in early-stage oral cancer: PETN0-study protocol.
    PLoS One. 2025;20:e0325032.
    PubMed     Abstract available
    
    
    
53. KONG D, Gao C, Yu Y, Yang L, et al
    The distribution characteristics of PD-1 pathway-related immune cells in esophageal cancer tissue and their prognostic significance.
    PLoS One. 2025;20:e0325349.
    PubMed     Abstract available
    
    
    
54. NTOUKAS SM, McNeely ML, Prado CM, Courneya KS, et al
    Feasibility and preliminary efficacy of heavy Lifting Strength Training versus Usual Care in Head and Neck Cancer Survivors (the LIFTING 2 Trial): A study protocol for a single-centre, phase II, randomized controlled trial.
    PLoS One. 2025;20:e0326860.
    PubMed     Abstract available
    
    
    
55. LI C, Li Q, Shi X, Han S, et al
    Papillary thyroid microcarcinoma and papillary thyroid carcinoma: Clinical characteristics and stratification of treatment strategies.
    PLoS One. 2025;20:e0327423.
    PubMed     Abstract available
    
    
    
56. OUYANG H, Dou X, Li X, Cao M, et al
    Sex disparities in papillary thyroid cancer survival: Divergent patterns of relative and absolute effects across the age spectrum.
    PLoS One. 2025;20:e0328876.
    PubMed     Abstract available
    
    
    
57. LAI Y, Liu R, Shao H, Zhan J, et al
    Mechanism of Astragaloside-Brucea javanica oil nanoemulsion against oral squamous cell carcinoma through CDK1/MTFR2: Network pharmacology, bioinformatics, and experimental studies.
    PLoS One. 2025;20:e0329622.
    PubMed     Abstract available
    
    
    
58. MOPOSITA MOLINA FD, Agnes G, Zandona MR, Izquierdo R, et al
    Prevalence and diagnostic reliability of BRAF, RAS mutations, and RET/PTC rearrangements in a Latin American public health service population with thyroid nodular disease.
    PLoS One. 2025;20:e0329407.
    PubMed     Abstract available
    
    
    
59. LARSEN KD, Hvilsom GB, Andersen TV, Homoe P, et al
    Spinal needles versus conventional needles for fine-needle aspiration biopsy of thyroid nodules-A multicenter randomized controlled trial.
    PLoS One. 2025;20:e0321043.
    PubMed     Abstract available
    
    
    
60. KURAHASHI Y, Tomita T, Okugawa T, Kitajima K, et al
    Preoperative assessment using a scoring system after neoadjuvant chemotherapy with docetaxel, cisplatin, and 5-fluorouracil for locally advanced esophageal cancer: Who can avoid surgery?
    PLoS One. 2025;20:e0328835.
    PubMed     Abstract available
    
    
    
61. DE ROEST RH, Buijze M, Veth M, de Lint K, et al
    An unexpected role of CLASP1 in radiation response and S-phase regulation of head and neck cancer cells.
    PLoS One. 2025;20:e0329731.
    PubMed     Abstract available
    
    
    
62. ZHOU J, Liu S, Deng J, He L, et al
    Premature termination of DNA Damage Repair by 3-Methyladenine potentiates cisplatin cytotoxicity in nasopharyngeal carcinoma cells.
    PLoS One. 2025;20:e0329272.
    PubMed     Abstract available
    
    
    
63. BRUCKNER J, Rohrer Bley C, Rampazzo A, Unterkirhers S, et al
    Evaluation of acute ocular toxicity after definitive-intent radiation therapy in canine sinonasal tumors.
    PLoS One. 2025;20:e0329073.
    PubMed     Abstract available
    
    
    
64. CHEN B, Zhan Z, Yu S, Huang J, et al
    Burden of laryngeal cancer attributable to occupational asbestos exposure in China: A comprehensive analysis from 1990 to 2021.
    PLoS One. 2025;20:e0330878.
    PubMed     Abstract available
    
    
    
65. GAO W, Yuan H, Qing S
    Bioinformatics analysis and experimental validation of the potential relationship between bacterial lipopolysaccharide and oral squamous cell carcinoma.
    PLoS One. 2025;20:e0329231.
    PubMed     Abstract available
    
    
    
66. PREVOST A, Poncet H, Benvegnu V, Poulet V, et al
    Curative treatment incorporating subjective decisions on age and frailty is not beneficial for older patients with oral cavity squamous cell carcinoma.
    PLoS One. 2025;20:e0330376.
    PubMed     Abstract available
    
    
    
67. QIU L, Wu R, Chen Y, Xiang H, et al
    Dosimetry study of 3D-printed noncoplanar template-assisted CT-guided 125I seed implantation for the treatment of recurrent and metastatic tumors in the head and neck.
    PLoS One. 2025;20:e0330271.
    PubMed     Abstract available
    
    
    
68. PACHECO MCD, Prado AHDR, da Costa DV, de Arantes LC, et al
    Survival of dental implants in irradiated head and neck cancer patients compared to non-irradiated patients: An umbrella review.
    PLoS One. 2025;20:e0324388.
    PubMed     Abstract available
    
    
    
69. OCCOMORE-KENT LC, Stavropoulou C, Ward EC, Elkington C, et al
    Training and competency frameworks used in the preparation of healthcare professionals for head and neck cancer screening: A scoping review protocol.
    PLoS One. 2025;20:e0330664.
    PubMed     Abstract available
    
    
    
70. KHAN A, Fawzy WMS, Habib SS, Sultan M, et al
    Integrated comparative analysis of T-staging of laryngeal carcinoma on parallel versus non-parallel vocal cord CT planes with its potential treatment pitfalls.
    PLoS One. 2025;20:e0330389.
    PubMed     Abstract available
    
    
    
71. DENG M, Lin Y, Yan L, Fei Z, et al
    Global burden of head and neck cancer from 1990 to 2021: A comprehensive analysis and projections to 2030 based on the global burden of disease study 2021.
    PLoS One. 2025;20:e0330805.
    PubMed     Abstract available
    
    
    
72. TAMAYO-CABEZA G, Anillo-Gonzalez V, Orozco-Paez J, Rodriguez-Cavallo E, et al
    Translocator protein (TSPO) analysis in saliva of adults with oral mucosal lesions: A preliminary study.
    PLoS One. 2025;20:e0330065.
    PubMed     Abstract available
    
    
    
73. SHU T, Wu X, Wei C, Chen C, et al
    ETS2 targets ZMYND11 to inhibit thyroid cancer progression via the mTOR signaling pathway.
    PLoS One. 2025;20:e0328881.
    PubMed     Abstract available
    
    
    
74. LI F, Chen W, Chen Z, Lian B, et al
    Genotype-phenotype correlations of germline mutations in exon 10 of the RET proto-oncogene from 14 MEN2A families of Ethnic Han Chinese.
    PLoS One. 2025;20:e0332136.
    PubMed     Abstract available
    
    
    
75. LIN R, Qin R, Zhang Y, Guan Y, et al
    Combined application of BNLF2b antibody with VCA-IgA, Rta-IgG, and Zta-IgA in nasopharyngeal carcinoma screening in the Guangxi region.
    PLoS One. 2025;20:e0332606.
    PubMed     Abstract available
    
    
    
76. CLATOT F, Even C, Daste A, Borel C, et al
    Defining a need for rapid response and practical guidance for recurrent and metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) management in France: A Delphi consensus.
    PLoS One. 2025;20:e0332413.
    PubMed     Abstract available
    
    
    
77. LIN CH, Chang CC, Lee HH, Chou YS, et al
    Reduced complications and mortality after admission for head and neck cancer in patients with previous dental scaling: a retrospective cohort study based on real-world data.
    PLoS One. 2025;20:e0332992.
    PubMed     Abstract available
    
    
    
78. MUTAI RC, Mweu MM
    Association between traditional fermented milk (mursik) consumption and oesophageal carcinoma among patients presenting to two referral hospitals in Nandi County, Kenya: A case-control study.
    PLoS One. 2025;20:e0324412.
    PubMed     Abstract available
    
    
    January 2024
79. CHIU WC, Wu ZF, Lee MS, Chen JY, et al
    Propofol-based total intravenous anesthesia is associated with less postoperative recurrence than desflurane anesthesia in thyroid cancer surgery.
    PLoS One. 2024;19:e0296169.
    PubMed     Abstract available
    
    
    
80. MULLAN LJ, Blackburn NE, Lorimer J, Semple CJ, et al
    Evaluating the effects of lymphoedema management strategies on functional status and health-related quality of life following treatment for head and neck cancer: Protocol for a systematic review.
    PLoS One. 2024;19:e0297757.
    PubMed     Abstract available
    
    
    
81. KHONGWIROTPHAN S, Oonsiri S, Kitpanit S, Prayongrat A, et al
    Multimodality radiomics for tumor prognosis in nasopharyngeal carcinoma.
    PLoS One. 2024;19:e0298111.
    PubMed     Abstract available
    
    
    
82. NGUYEN V, Schrank TP, Major MB, Weissman BE, et al
    ARID1A loss is associated with increased NRF2 signaling in human head and neck squamous cell carcinomas.
    PLoS One. 2024;19:e0297741.
    PubMed     Abstract available
    
    
    
83. WAKISAKA N, Moriyama-Kita M, Kondo S, Kobayashi E, et al
    Lymph node metastasis regulation by peritumoral tonsillar tissue mitochondria-related pathway activation in oropharyngeal cancer.
    PLoS One. 2024;19:e0299750.
    PubMed     Abstract available
    
    
    
84. KUO CY, Tsai CH, Wu JK, Cheng SP, et al
    Sublethal thermal stress promotes migration and invasion of thyroid cancer cells.
    PLoS One. 2024;19:e0298903.
    PubMed     Abstract available
    
    
    
85. LU H, Bei Y, Wang C, Deng X, et al
    A retrospective cohort study to observe the efficacy and safety of Endoscopic Submucosal Dissection (ESD) with adjuvant radiotherapy for T1a-MM/T1b-SM Esophageal Squamous Cell Carcinoma (ESCC).
    PLoS One. 2024;19:e0298792.
    PubMed     Abstract available
    
    
    
86. GUNNING JA, Gilman KE, Zuniga TM, Simpson RJ, et al
    Parotid glands have a dysregulated immune response following radiation therapy.
    PLoS One. 2024;19:e0297387.
    PubMed     Abstract available
    
    
    
87. WANG P, Soh KL, Japar SB, Khazaai HB, et al
    Assessing malnutrition in patients with nasopharyngeal carcinoma: Diagnostic protocol for the development and validation of a new nutritional assessment tool.
    PLoS One. 2024;19:e0300067.
    PubMed     Abstract available
    
    
    
88. AN R, Gu YX, Ni XH, Lei Y, et al
    The feasibility and clinical significance of lateral approach thyroidectomy.
    PLoS One. 2024;19:e0300604.
    PubMed     Abstract available
    
    
    
89. JIN X, Yin Z, Li X, Guo H, et al
    TIM3 activates the ERK1/2 pathway to promote invasion and migration of thyroid tumors.
    PLoS One. 2024;19:e0297695.
    PubMed     Abstract available
    
    
    
90. PAO TH, Chen YY, Chang WL, Wu SY, et al
    Lymph node volume predicts survival in esophageal squamous cell carcinoma treated with neoadjuvant chemoradiotherapy and surgery.
    PLoS One. 2024;19:e0300173.
    PubMed     Abstract available
    
    
    
91. RUSANEN P, Marttila E, Amatya SB, Hagstrom J, et al
    Expression of Toll-like receptors in oral squamous cell carcinoma.
    PLoS One. 2024;19:e0300437.
    PubMed     Abstract available
    
    
    
92. MONTAGNOLI DRABS, Leite VF, Godoy YS, Lafeta VM, et al
    Can predictive factors determine the time to treatment initiation for oral and oropharyngeal cancer? A classification and regression tree analysis.
    PLoS One. 2024;19:e0302370.
    PubMed     Abstract available
    
    
    
93. SASAKI A, Takeda D, Kawai H, Tadokoro Y, et al
    Transcutaneous carbon dioxide suppresses skeletal muscle atrophy in a mouse model of oral squamous cell carcinoma.
    PLoS One. 2024;19:e0302194.
    PubMed     Abstract available
    
    
    
94. XIE L, He L, Zhang W, Wang H, et al
    Functional analysis of ESM1 by shRNA-mediated knockdown of its expression in papillary thyroid cancer cells.
    PLoS One. 2024;19:e0298631.
    PubMed     Abstract available
    
    
    
95. JIANG W, Xu S, Li P
    SLC2A3 promotes tumor progression through lactic acid-promoted TGF-beta signaling pathway in oral squamous cell carcinoma.
    PLoS One. 2024;19:e0301724.
    PubMed     Abstract available
    
    
    
96. TALANI C, Hogmo A, Laurell G, Makitie A, et al
    Six-month mortality has decreased for patients with curative treatment intent for head and neck cancer in Sweden.
    PLoS One. 2024;19:e0296534.
    PubMed     Abstract available
    
    
    
97. ZHANG X, Yu J, Zhu J, Wei H, et al
    A meta-analysis of unilateral axillary approach for robotic surgery compared with open surgery for differentiated thyroid carcinoma.
    PLoS One. 2024;19:e0298153.
    PubMed     Abstract available
    
    
    
98. MIKI Y, Nishi S, Tamura T, Imai T, et al
    Protocol of a pilot randomized clinical trial to evaluate nutritional support and rehabilitation on prevention of skeletal muscle mass loss during neoadjuvant chemotherapy in patients with esophageal cancer.
    PLoS One. 2024;19:e0302003.
    PubMed     Abstract available
    
    
    
99. GOTO H, Oshikiri T, Kato T, Nagatani Y, et al
    Protocol for a phase II study to evaluate the efficacy and safety of nivolumab as a postoperative adjuvant therapy for patients with esophageal cancer treated with preoperative docetaxel, cisplatin plus 5-fluorouracil treatment (PENTAGON trial).
    PLoS One. 2024;19:e0299742.
    PubMed     Abstract available
    
    
    
100. OSEI SAAHENE R, Barnes P, Yeboah FA, Agbo E, et al
     Expression of RAS and RAB interactor 1 (RIN1) in head and neck tumors at selected hospital in Ghana.
     PLoS One. 2024;19:e0301295.
     PubMed     Abstract available
     
     
     
101. ANWAR N, Chundriger Q, Awan S, Moatter T, et al
     Prevalence of high-risk human papillomavirus in oral squamous cell carcinoma with or without chewing habits.
     PLoS One. 2024;19:e0300354.
     PubMed     Abstract available
     
     
     
102. KORIAKINA N, Sladoje N, Basic V, Lindblad J, et al
     Deep multiple instance learning versus conventional deep single instance learning for interpretable oral cancer detection.
     PLoS One. 2024;19:e0302169.
     PubMed     Abstract available
     
     
     
103. GUO H, Shu J, Hu G, Liu B, et al
     Downregulation of RCN1 inhibits esophageal squamous cell carcinoma progression and M2 macrophage polarization.
     PLoS One. 2024;19:e0302780.
     PubMed     Abstract available
     
     
     
104. ZHANG Q, Li M, Jin X, Zhou R, et al
     Comparison of interventions for Barrett's esophagus: A network meta-analysis.
     PLoS One. 2024;19:e0302204.
     PubMed     Abstract available
     
     
     
105. ZHONG X, Shang J, Zhang R, Zhang X, et al
     Explore the shared molecular mechanism between dermatomyositis and nasopharyngeal cancer by bioinformatic analysis.
     PLoS One. 2024;19:e0296034.
     PubMed     Abstract available
     
     
     
106. HE C, Mi X, Xu G, Xu X, et al
     Cost-effectiveness analysis of tislelizumab plus chemotherapy as the first-line treatment for advanced or metastatic oesophageal squamous cell carcinoma in China.
     PLoS One. 2024;19:e0302961.
     PubMed     Abstract available
     
     
     
107. MORE DA, Singh N, Mishra R, Muralidharan HP, et al
     Intronic miR-6741-3p targets the oncogene SRSF3: Implications for oral squamous cell carcinoma pathogenesis.
     PLoS One. 2024;19:e0296565.
     PubMed     Abstract available
     
     
     
108. TABATABAIE-ZADEH SA, Mahdavi N, Mahdaviani B, Selk-Ghaffari M, et al
     Evaluating the association between lifetime physical activity and oral squamous cell carcinoma: A case-control study.
     PLoS One. 2024;19:e0303929.
     PubMed     Abstract available
     
     
     
109. PANDIT S, Sapkota S, Adhikari A, Karki P, et al
     Ethno-geographic distribution and histopathological classification of nasopharyngeal carcinoma in a single center in Nepal.
     PLoS One. 2024;19:e0304371.
     PubMed     Abstract available
     
     
     
110. NGUYEN PT, Shimojukkoku Y, Kajiya Y, Oku Y, et al
     Gene alterations in the nuclear transport receptor superfamily: A study of head and neck cancer.
     PLoS One. 2024;19:e0300446.
     PubMed     Abstract available
     
     
     
111. CHEN M, Wang F, Xie X, Yang X, et al
     Application of bundled process control in the prevention of pressure injury in patients with head and neck cancer.
     PLoS One. 2024;19:e0305190.
     PubMed     Abstract available
     
     
     
112. KLIMZA H, Mackowiak B, Zagaja K, Jackowska J, et al
     The usefulness of narrow-band Imaging (NBI) in nasopharyngeal lesions-Validation of the Ni NBI classification dedicated for vascular pattern in the nasopharynx.
     PLoS One. 2024;19:e0302043.
     PubMed     Abstract available
     
     
     
113. YANG D, Zhang Q, Kuang H, Liu J, et al
     The anti-tumor activity of tangeretin in esophageal squamous cell carcinoma by inhibiting GLI2-mediated transcription of GPNMB.
     PLoS One. 2024;19:e0291531.
     PubMed     Abstract available
     
     
     
114. ALHASSAN D, Olbricht GR, Adekpedjou A
     Differential methylation region detection via an array-adaptive normalized kernel-weighted model.
     PLoS One. 2024;19:e0306036.
     PubMed     Abstract available
     
     
     
115. YOSHIDA T, Yagi N, Ogawa T, Nakanome A, et al
     Breathing-Swallowing discoordination after definitive chemoradiotherapy for head and neck cancers is associated with aspiration pneumonia.
     PLoS One. 2024;19:e0305560.
     PubMed     Abstract available
     
     
     
116. SU J, Huang W, Yu P
     Effect of inspiratory muscle training in esophageal cancer patients receiving esophagectomy: A meta-analysis of randomized controlled trials.
     PLoS One. 2024;19:e0307069.
     PubMed     Abstract available
     
     
     
117. BAUDE J, Guigou C, Thibouw D, Vulquin N, et al
     Definitive radio(chemo)therapy versus upfront surgery in the treatment of HPV-related localized or locally advanced oropharyngeal squamous cell carcinoma.
     PLoS One. 2024;19:e0307658.
     PubMed     Abstract available
     
     
     
118. DE BRESSER CJM, van Nesselrooij BPM, van Treijen MJC, Braat AJAT, et al
     Head and Neck Paraganglioma (HNPGL) Registry: A study protocol for prospective data collection in patients with Head and Neck Paragangliomas.
     PLoS One. 2024;19:e0307311.
     PubMed     Abstract available
     
     
     
119. MOHARRAMI M, Azimian Zavareh P, Watson E, Singhal S, et al
     Prognosing post-treatment outcomes of head and neck cancer using structured data and machine learning: A systematic review.
     PLoS One. 2024;19:e0307531.
     PubMed     Abstract available
     
     
     
120. SONG L, Li B, Wu H, Wu C, et al
     Understanding the factors of wearable devices among the patients with thyroid cancer: A modified UTAUT2 model.
     PLoS One. 2024;19:e0305944.
     PubMed     Abstract available
     
     
     
121. NARASIMHAN P, Levy AR, Rogers SN, Schache AG, et al
     A protocol for the longitudinal investigation of cancer related fatigue in head and neck cancer with an emphasis on the role of physical activity.
     PLoS One. 2024;19:e0308400.
     PubMed     Abstract available
     
     
     
122. FELSER S, Rogahn J, Glass A, Bonke LA, et al
     Feasibility of individualized home exercise programs for patients with head and neck cancer-study protocol and first results of a multicentre single-arm intervention trial (OSHO #94).
     PLoS One. 2024;19:e0301304.
     PubMed     Abstract available
     
     
     
123. LIU T, Xu J, Zhang QX, Huang YJ, et al
     Inhibiting the expression of spindle appendix cooled coil protein 1 can suppress tumor cell growth and metastasis and is associated with cancer immune cells in esophageal squamous cell carcinoma.
     PLoS One. 2024;19:e0302312.
     PubMed     Abstract available
     
     
     
124. JARUTHIEN T, Lertbutsayanukul C, Jittapiromsak N, Sriyook A, et al
     Development and validation of a practical score to predict 3-year distant metastatic free survival in nasopharyngeal carcinoma incorporating the number of lymph node regions.
     PLoS One. 2024;19:e0309436.
     PubMed     Abstract available
     
     
     
125. AWODUTIRE P, Kattan M, Akadiri OA
     Development and validation of accelerated failure time model for cause-specific survival and prognostication of oral squamous cell carcinoma: SEER data analysis.
     PLoS One. 2024;19:e0309214.
     PubMed     Abstract available
     
     
     
126. SOARES AA, Nagashima YG, Alves CX, de Medeiros KS, et al
     Zinc and thyroid cancer: A systematic review and meta-analysis protocol.
     PLoS One. 2024;19:e0307617.
     PubMed     Abstract available
     
     
     
127. TAN J, Dong X, Liu H
     Mitochondrial DNA is a sensitive surrogate and oxidative stress target in oral cancer cells.
     PLoS One. 2024;19:e0304939.
     PubMed     Abstract available
     
     
     
128. SUN X, Niwa T, Kazama T, Okazaki T, et al
     Preoperative dual-energy computed tomography and positron-emission tomography evaluation of lymph node metastasis in esophageal squamous cell carcinoma.
     PLoS One. 2024;19:e0309653.
     PubMed     Abstract available
     
     
     
129. SAWADA T, Kondo M, Goto M, Murakami M, et al
     Cost-utility analysis of proton beam therapy for locally advanced esophageal cancer in Japan.
     PLoS One. 2024;19:e0308961.
     PubMed     Abstract available
     
     
     
130. NEMATI S, Islami F, Kamangar F, Poustchi H, et al
     Improvement of esophageal cancer survival in Northeast Iran: A two-decade journey in a high-risk, low- resource region.
     PLoS One. 2024;19:e0310842.
     PubMed     Abstract available
     
     
     
131. ZHU X, Mo M, Zheng S, Han K, et al
     Comparing the prognosis of esophageal adenocarcinoma with bone and liver metastases: A competing risk analysis.
     PLoS One. 2024;19:e0303842.
     PubMed     Abstract available
     
     
     
132. ALFURAIH AM, Alotaibi AM, Alshammari AK, Alrashied BF, et al
     Evaluating diagnostic accuracy and agreement of TI-RADS scoring in thyroid nodules: A comparative analysis between sonographers and radiologists.
     PLoS One. 2024;19:e0312121.
     PubMed     Abstract available
     
     
     
133. HERNANDEZ D, Nam T, Lee E, Lee JJ, et al
     Design of multi-modal antenna arrays for microwave hyperthermia and 1H/1(9)F MRI monitoring of drug release.
     PLoS One. 2024;19:e0312343.
     PubMed     Abstract available
     
     
     
134. HOSOKAWA K, Takenaka Y, Sato T, Tsuda T, et al
     Small-cell carcinoma in the head and neck region: A propensity score-matched analysis of the effect of surgery.
     PLoS One. 2024;19:e0312455.
     PubMed     Abstract available
     
     
     
135. HSIEH HC, Chen CY, Chou CH, Peng BY, et al
     Deep learning-based automatic image classification of oral cancer cells acquiring chemoresistance in vitro.
     PLoS One. 2024;19:e0310304.
     PubMed     Abstract available
     
     
     
136. TANDON A, Sandhya K, Singh NN, Gulati N, et al
     Decoding lymphangiogenesis in oral squamous cell carcinoma: Emphasis on clinical and histopathological determinants of regional metastasis.
     PLoS One. 2024;19:e0311108.
     PubMed     Abstract available
     
     
     
137. JIA W, Li C, Liu C, Hu R, et al
     Survival benefit of adjuvant therapy following neoadjuvant therapy in patients with resected esophageal cancer: A retrospective cohort study.
     PLoS One. 2024;19:e0304937.
     PubMed     Abstract available
     
     
     
138. TAMURA K, Takenaka Y, Hosokawa K, Sato T, et al
     Effect of immortal time bias on the association between immune-related adverse events and oncological outcomes following immune checkpoint inhibitors therapy for head and neck squamous cell carcinoma.
     PLoS One. 2024;19:e0314209.
     PubMed     Abstract available
     
     
     
139. ZHENG Y, Yu J, Zhou Y, Lu Q, et al
     Development and validation of a predictive nomogram for vascular crises in oral and maxillofacial cancer patients undergoing free flap surgery.
     PLoS One. 2024;19:e0314676.
     PubMed     Abstract available
     
     
     
140. GUMUS A, Sonmez D, Demirkol S, Tolgahan Hakan M, et al
     Impact of CD40 (rs1883832) and CD40L (rs1126535) gene variants on laryngeal cancer susceptibility and their association with serum biomarker levels of sCD40 and sCD40L.
     PLoS One. 2024;19:e0312576.
     PubMed     Abstract available
     
     
     
141. LIANG QW, Gao XL, Zhang JW
     Nomogram for predicting early death in elderly patients with laryngeal squamous cell carcinoma: A population-based SEER study.
     PLoS One. 2024;19:e0315102.
     PubMed     Abstract available
     
     
     
142. HAMMACHE M, Benchekroun S, Alamri A, Jalouli M, et al
     Modulation of signature cancer-related genes in oral cancer cells (Ca9-22) by anethole treatment: Insights into therapeutic potential.
     PLoS One. 2024;19:e0315085.
     PubMed     Abstract available
     
     
     
143. QIN L, Tian J, Zhang Y, Yin Y, et al
     Comparison of postoperative survival prognosis between early-onset and late-onset esophageal cancer: A Population-based study.
     PLoS One. 2024;19:e0315391.
     PubMed     Abstract available
     
     
     
144. EBOSHIDA N, Hamada A, Higaki M, Obayashi F, et al
     Potential role of circulating tumor cells and cell-free DNA as biomarkers in oral squamous cell carcinoma: A prospective single-center study.
     PLoS One. 2024;19:e0309178.
     PubMed     Abstract available
     
     
     
145. DEE W, Alaaeldin Ibrahim R, Marouli E
     Histopathological domain adaptation with generative adversarial networks: Bridging the domain gap between thyroid cancer histopathology datasets.
     PLoS One. 2024;19:e0310417.
     PubMed     Abstract available
     
     
     
146. YEH SA, Chiu LC, Lin HC, Li HJ, et al
     Trends in the incidence of the Epstein-Barr virus-associated malignancies extranodal NK/T-cell lymphoma and nasopharyngeal carcinoma in Taiwan.
     PLoS One. 2024;19:e0315380.
     PubMed     Abstract available
     
     
     January 2023
147. YANG J, Zhang J, Chen J, Yang X, et al
     Thymidylate synthase promotes esophageal squamous cell carcinoma growth by relieving oxidative stress through activating nuclear factor erythroid 2-related factor 2 expression.
     PLoS One. 2023;18:e0290264.
     PubMed     Abstract available
     
     
     
148. WU Q, Chang Y, Yang C, Liu H, et al
     Adjuvant chemotherapy or no adjuvant chemotherapy? A prediction model for the risk stratification of recurrence or metastasis of nasopharyngeal carcinoma combining MRI radiomics with clinical factors.
     PLoS One. 2023;18:e0287031.
     PubMed     Abstract available
     
     
     
149. MASROUR M, Khanmohammadi S, Fallahtafti P, Rezaei N, et al
     Long non-coding RNA as a potential diagnostic biomarker in head and neck squamous cell carcinoma: A systematic review and meta-analysis.
     PLoS One. 2023;18:e0291921.
     PubMed     Abstract available
     
     
     
150. COSTA EM, Magalhaes Rodrigues ES, de Sousa FS, Pimentel FB, et al
     The Brazilian National Oral Health Policy and oral cancer mortality trends: An autoregressive integrated moving average (ARIMA) model.
     PLoS One. 2023;18:e0291609.
     PubMed     Abstract available
     
     
     
151. JUNG S, Kim B, Lee SY, Chang WI, et al
     Novel tongue-positioning device to reduce tongue motions during radiation therapy for head and neck cancer: Geometric and dosimetric evaluation.
     PLoS One. 2023;18:e0291712.
     PubMed     Abstract available
     
     
     
152. LIU Y, Yan M
     Trends in all causes and cause specific mortality attributable to ambient particulate matter pollution in China from 1990 to 2019: A secondary data analysis study.
     PLoS One. 2023;18:e0291262.
     PubMed     Abstract available
     
     
     
153. MAEKAWA N, Konnai S, Hosoya K, Kim S, et al
     Safety and clinical efficacy of an anti-PD-L1 antibody (c4G12) in dogs with advanced malignant tumours.
     PLoS One. 2023;18:e0291727.
     PubMed     Abstract available
     
     
     
154. IEZADI S, Ebrahimi N, Ghamari SH, Esfahani Z, et al
     Global and regional quality of care index (QCI) by gender and age in oesophageal cancer: A systematic analysis of the Global Burden of Disease Study 1990-2019.
     PLoS One. 2023;18:e0292348.
     PubMed     Abstract available
     
     
     
155. NGUYEN TPA, Gautam S, Mahato S, Jensen OC, et al
     Overview of oral health status and associated risk factors in maritime settings: An updated systematic review.
     PLoS One. 2023;18:e0293118.
     PubMed     Abstract available
     
     
     
156. SHANG F, Liu X, Ren X, Li Y, et al
     Competing-risks model for predicting the prognostic value of lymph nodes in medullary thyroid carcinoma.
     PLoS One. 2023;18:e0292488.
     PubMed     Abstract available
     
     
     
157. KHAN A, Fawzy WMS, Habib SS, Sultan M, et al
     Novel and pragmatic exploration of variation in glottic parameters in non-parallel versus parallel vocal cord CT planes with potential reporting pitfalls.
     PLoS One. 2023;18:e0293659.
     PubMed     Abstract available
     
     
     
158. GU H, Li T, Beeraka NM, Zheng Y, et al
     Molecular classification of human papilloma virus-negative head and neck squamous cell carcinomas: Cell cycle-based classifier and prognostic signature.
     PLoS One. 2023;18:e0286414.
     PubMed     Abstract available
     
     
     
159. BRIGDEN T, Mitchell C, Redrup Hill E, Hall A, et al
     Ethical and legal implications of implementing risk algorithms for early detection and screening for oesophageal cancer, now and in the future.
     PLoS One. 2023;18:e0293576.
     PubMed     Abstract available
     
     
     
160. KANZOW P, Mielke K, Haupt F, Wiegand S, et al
     Oral health in patients with different sites of head and neck squamous cell carcinoma is not different.
     PLoS One. 2023;18:e0293665.
     PubMed     Abstract available
     
     
     
161. MUANGWONG P, Homkham N, Narueban W, Tadadoltip C, et al
     Longitudinal measurements of neutrophil-to-lymphocyte ratio in nasopharyngeal cancer treated with concurrent chemoradiotherapy.
     PLoS One. 2023;18:e0292591.
     PubMed     Abstract available
     
     
     
162. HOSSEINIYAN KHATIBI SM, Zununi Vahed S, Homaei Rad H, Emdadi M, et al
     Uncovering key molecular mechanisms in the early and late-stage of papillary thyroid carcinoma using association rule mining algorithm.
     PLoS One. 2023;18:e0293335.
     PubMed     Abstract available
     
     
     
163. KANANKULAM VELLIANGIRI S, Ballal S, Prasad Yadhav M, Tripathi M, et al
     A long-term retrospective cohort-based risk-benefit analysis of augmenting total cumulative I-131 activity to 37GBq in differentiated thyroid cancer patients with skeletal metastases.
     PLoS One. 2023;18:e0294343.
     PubMed     Abstract available
     
     
     
164. HEO J, Lee S, Park J, Yang H, et al
     Age-associated mortality is partially mediated by TERT promoter mutation status in differentiated thyroid carcinoma.
     PLoS One. 2023;18:e0294145.
     PubMed     Abstract available
     
     
     
165. ZAMANI N, Szymiczek A, Shakeri R, Poustchi H, et al
     A Single nucleotide polymorphism in the ALDH2 gene modifies the risk of esophageal squamous cell carcinoma in BRCA2 p.K3326* carriers.
     PLoS One. 2023;18:e0292611.
     PubMed     Abstract available
     
     
     
166. SHETAKE NG, Kumar A, Huilgol N, Pandey BN, et al
     Diagnostic potential of serum HSP90 beta for HNSCC and its therapeutic prognosis after local hyperthermia therapy.
     PLoS One. 2023;18:e0281919.
     PubMed     Abstract available
     
     
     
167. ZOU M, Liang Q, Zhang W, Zhu Y, et al
     Causal association between dietary factors and esophageal diseases: A Mendelian randomization study.
     PLoS One. 2023;18:e0292113.
     PubMed     Abstract available
     
     
     
168. SCHAEFFERS AWMA, Devriese LA, van Gils CH, Dankbaar JW, et al
     Low dose cisplatin weekly versus high dose cisplatin every three weeks in primary chemoradiotherapy in head and neck cancer patients with low skeletal muscle mass: The CISLOW-study protocol.
     PLoS One. 2023;18:e0294147.
     PubMed     Abstract available
     
     
     
169. SONG WJ, Um IC, Kwon SR, Lee JH, et al
     Predictive factors of lymph node metastasis in papillary thyroid cancer.
     PLoS One. 2023;18:e0294594.
     PubMed     Abstract available
     
     
     
170. BUSS LG, De Oliveira Pessoa D, Snider JM, Padi M, et al
     Metabolomics analysis of pathways underlying radiation-induced salivary gland dysfunction stages.
     PLoS One. 2023;18:e0294355.
     PubMed     Abstract available
     
     
     
171. TATEAI Y, Kawakami K, Teramae M, Fukuda N, et al
     Factors associated with lenvatinib adherence in thyroid cancer and hepatocellular carcinoma.
     PLoS One. 2023;18:e0294320.
     PubMed     Abstract available
     
     
     
172. ALOLAYAN WR, Rieger JM, Yoon MN
     Head and neck cancer treatment outcome priorities: A multi-perspective concept mapping study.
     PLoS One. 2023;18:e0294712.
     PubMed     Abstract available
     
     
     
173. MIRAKI FERIZ A, Bahraini F, Khosrojerdi A, Azarkar S, et al
     Deciphering the immune landscape of head and neck squamous cell carcinoma: A single-cell transcriptomic analysis of regulatory T cell responses to PD-1 blockade therapy.
     PLoS One. 2023;18:e0295863.
     PubMed     Abstract available
     
     
     
174. SACCO A, Battaglia AM, Santamaria G, Buffone C, et al
     SOX2 promotes a cancer stem cell-like phenotype and local spreading in oral squamous cell carcinoma.
     PLoS One. 2023;18:e0293475.
     PubMed     Abstract available
     
     
     
175. FANG Q, Dai L, Zhang X, Luo R, et al
     Number and ratio of metastatic lymph nodes impacts the prognosis of submandibular gland cancer.
     PLoS One. 2023;18:e0296040.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge.